Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $63.48 -2.1%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 10 | New: 15
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 10 | New: 15
Join SI Premium – FREE
Wedbush analyst Martin Fan raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Doncasters (DPC) indicating open around $40, IPO priced at $33
- Jack Henry and Google Cloud expand AI security collaboration for banks
- Increasing unusual put volume: WEN CHYM AS PURR DFTX
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
